Skip to content

Withings Devices Follow-up Study - Hypertension

Withings Devices Follow-up Study - Hypertension

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06692413
Enrollment
0
Registered
2024-11-18
Start date
2024-11-01
Completion date
2024-11-01
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The primary objective is to evaluate the accuracy to predict uncontrolled hypertension with Withings device data.

Interventions

OTHERQuestionnaire

Users who consent to the study will receive a questionnaire every 3 months

Sponsors

Withings
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female who are 21 years of age or older, * Participant living in the United States, * Participant with data recorded in WITHINGS database, * Active WITHINGS device users having at least 2 years of data, * Subject able to read, understand, and provide written informed consent, * Subject willing and able to participate in the study procedures as described in the consent form, * Subject able to communicate effectively with and willing to follow instructions from the study staff.

Exclusion criteria

* Minors under 21 years old, * Subject who refused to participate in the study, * Subject who did not reply to the questionnaire, * Subject who objected to the processing of his or her data after the start of the study.

Design outcomes

Primary

MeasureTime frameDescription
Prediction of uncontrolled hypertension2 yearsCorrelation between uncontrolled hypertension, Withings data, and survey answers

Secondary

MeasureTime frameDescription
Correlation between Framingham risk score and EQ-5D-5L answers and Withings data2 yearsCorrelation between Framingham risk score and EQ-5D-5L answers and Withings data
Number of Questionnaires answers per participant2 yearsNumber of Questionnaires answers per participant

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORde Havenon, MD

Yale University School of Medicine, Dept of Neurology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026